Form 4: LeMaitre Vascular CFO LeBlanc Reports Acquisition of 1,221 Shares

Chief Financial Officer Dorian Paul LeBlanc reports acquiring 1,221 shares of LeMaitre Vascular Inc. common stock on March 10, 2025, through a restricted stock unit award.

Summary

• Dorian Paul LeBlanc, CFO of LeMaitre Vascular Inc. (LMAT), filed a Form 4 on March 21, 2025, reporting a change in beneficial ownership.
• On March 10, 2025, LeBlanc acquired 1,221 shares of common stock through a restricted stock unit (RSU) award.
• The RSU award vests over four years, with 25% vesting on the first anniversary of the grant date and the remaining balance vesting in equal annual installments over the subsequent three years.
• The issuer has a provision to withhold shares to cover withholding taxes due on each vesting date.
• Following the transaction, LeBlanc directly owns 1,221 shares of LeMaitre Vascular Inc. common stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it's a standard regulatory filing related to executive compensation. It doesn't inherently indicate positive or negative performance.

Positives

• The acquisition of shares by the CFO could be interpreted as a positive sign, indicating confidence in the company's future performance.

Future Outlook

The document does not contain any specific forward-looking statements or guidance.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates the CFO's acquisition of shares through a pre-determined compensation plan.

Stakeholder Impact

• The acquisition of shares by the CFO could have a minor positive impact on shareholder sentiment.

Key Dates

Keywords

Form 4, Beneficial Ownership, LeMaitre Vascular, LMAT, Dorian Paul LeBlanc, CFO, Restricted Stock Unit, RSU, Vesting